TRCT
DCTH icon

Tower Research Capital (TRC)’s Delcath Systems DCTH Stock Holding History

Tower Research Capital (TRC)’s Portfolio DCTH Stock Details DCTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7K Sell
1,089
-283
-21% -$3.13K ﹤0.01% 3843
2026
Q1 		$12.7K Buy
1,372
+243
+22% +$2.35K ﹤0.01% 3777
2025
Q4 		$11.4K Sell
1,129
-5,141
-82% -$51.1K ﹤0.01% 3603
2025
Q3 		$67.4K Buy
6,270
+3,338
+114% +$37.3K ﹤0.01% 2288
2025
Q2 		$39.9K Buy
+2,932
New +$40.9K ﹤0.01% 3166
2025
Q1 		– Sell
-14,694
Closed -$177K – 5295
2024
Q4 		$177K Buy
14,694
+13,529
+1,161% +$143K ﹤0.01% 1801
2024
Q3 		$10.5K Buy
1,165
+906
+350% +$7.87K ﹤0.01% 3747
2024
Q2 		$2.17K Sell
259
-6,725
-96% -$42.6K ﹤0.01% 5045
2024
Q1 		$33.3K Buy
6,984
+3,981
+133% +$17.2K ﹤0.01% 2567
2023
Q4 		$12.5K Sell
3,003
-3,880
-56% -$12.7K ﹤0.01% 4040
2023
Q3 		$27.9K Buy
6,883
+6,733
+4,489% +$31.6K ﹤0.01% 3083
2023
Q2 		$874 Sell
150
-4,513
-97% -$28.3K ﹤0.01% 5527
2023
Q1 		$26K Buy
4,663
+2,419
+108% +$10.7K ﹤0.01% 3146
2022
Q4 		$8K Sell
2,244
-787
-26% -$2.41K ﹤0.01% 4377
2022
Q3 		$10K Sell
3,031
-7
-0.2% -$28 ﹤0.01% 4520
2022
Q2 		$12K Buy
3,038
+1,275
+72% +$6.52K ﹤0.01% 4274
2022
Q1 		$11K Buy
+1,763
New +$11.8K ﹤0.01% 4159
2021
Q4 		– Sell
-554
Closed -$6K – 6200
2021
Q3 		$6K Sell
554
-781
-59% -$7.7K ﹤0.01% 4738
2021
Q2 		$17K Buy
+1,335
New +$15.3K ﹤0.01% 4033
2021
Q1 		– Sell
-100
Closed -$2K – 5450
2020
Q4 		$2K Sell
100
-926
-90% -$12.7K ﹤0.01% 4872
2020
Q3 		$12K Buy
1,026
+147
+17% +$1.64K ﹤0.01% 4020
2020
Q2 		$9K Buy
+879
New +$7.1K ﹤0.01% 4047

Other funds holding DCTH

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC)'s DCTH Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Delcath Systems (DCTH) stake by 21% in Q2 2026, selling an estimated $3.13K and leaving 1,089 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3843.

Tower Research Capital (TRC) first reported a position in DCTH in Q2 2020 and has held it in 22 quarters since. The position peaked at $177K in Q4 2024. 120 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

  • Tower Research Capital (TRC) held 1,089 shares of Delcath Systems worth $13.7K as of Q2 2026.
  • Tower Research Capital (TRC) sold 283 Delcath Systems shares in Q2 2026, an estimated $3.13K.
  • Delcath Systems made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3843 holding.
  • Tower Research Capital (TRC) first reported a position in Delcath Systems in Q2 2020 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s Delcath Systems position peaked at $177K in Q4 2024.
  • 120 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.